Drug Formulary information is intended for use by healthcare professionals. It is not intended to be medical advice. Some of the information, including information about funding for cancer drugs, does not apply to all patients. Cancer treatment plans are unique to each patient. If you are a patient, please speak with your healthcare team to understand how this information applies to you.
Severe weather warning in your area. Please stay indoors and stay safe. Read more
regimen
IRINRALT+ENCO+PNTM
- Cancer Type
- Gastrointestinal, Colorectal, Small bowel and appendix
- Intent
-
Palliative
- Regimen Category
-
Evidence-informed
- Funding Program
-
New Drug Funding Program Raltitrexed - Metastatic Colorectal Small Bowel or Appendiceal Cancer Exceptional Access Program Encorafenib - In combination with panitumumab and chemotherapy for previously untreated metastatic colorectal cancer, according to specific criteria
- Drugs Used
- PANitumumab , irinotecan , raltitrexed , encorafenib
Regimen Monograph
May 2026
Patient Info Sheet
Please see Drugs Used for related Patient Information Sheets. Patient Information Sheets are not yet available for this regimen.
Last Updated: July 21, 2026
